Teva Short Long Term Debt Total from 2010 to 2024
| TEVA Stock | USD 13.81 0.56 4.23% |
Short and Long Term Debt Total | First Reported 1986-03-31 | Previous Quarter 20.3 B | Current Value 20.2 B | Quarterly Volatility 10.9 B |
Check Teva Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Teva main balance sheet or income statement drivers, such as Depreciation And Amortization of 667.3 M, Interest Expense of 1.1 B or Total Revenue of 9.5 B, as well as many exotic indicators such as Price To Sales Ratio of 0.7, Dividend Yield of 0.0042 or PTB Ratio of 1.48. Teva financial statements analysis is a perfect complement when working with Teva Pharma Valuation or Volatility modules.
Teva | Short Long Term Debt Total |
Latest Teva Pharma's Short Long Term Debt Total Growth Pattern
Below is the plot of the Short Long Term Debt Total of Teva Pharma Industries over the last few years. It is Teva Pharma's Short and Long Term Debt Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Teva Pharma's overall financial position and show how it may be relating to other accounts over time.
| Short Long Term Debt Total | 10 Years Trend |
|
Short Long Term Debt Total |
| Timeline |
Teva Short Long Term Debt Total Regression Statistics
| Arithmetic Mean | 19,934,963,333 | |
| Geometric Mean | 13,075,790,243 | |
| Coefficient Of Variation | 48.47 | |
| Mean Deviation | 7,713,330,667 | |
| Median | 21,160,650,000 | |
| Standard Deviation | 9,661,707,628 | |
| Sample Variance | 93348594.3T | |
| Range | 35.8B | |
| R-Value | 0.56 | |
| Mean Square Error | 69323064.4T | |
| R-Squared | 0.31 | |
| Significance | 0.03 | |
| Slope | 1,203,685,536 | |
| Total Sum of Squares | 1306880319.9T |
Teva Short Long Term Debt Total History
About Teva Pharma Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Teva Pharma income statement, its balance sheet, and the statement of cash flows. Teva Pharma investors use historical funamental indicators, such as Teva Pharma's Short Long Term Debt Total, to determine how well the company is positioned to perform in the future. Although Teva Pharma investors may use each financial statement separately, they are all related. The changes in Teva Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Teva Pharma's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Teva Pharma Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Teva Pharma. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Short and Long Term Debt Total | 20.2 B | 21.2 B |
Teva Pharma Investors Sentiment
The influence of Teva Pharma's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Teva. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Teva Pharma's public news can be used to forecast risks associated with an investment in Teva. The trend in average sentiment can be used to explain how an investor holding Teva can time the market purely based on public headlines and social activities around Teva Pharma Industries. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Teva Pharma's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Teva Pharma's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Teva Pharma's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Teva Pharma.
Teva Pharma Implied Volatility | 36.76 |
Teva Pharma's implied volatility exposes the market's sentiment of Teva Pharma Industries stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Teva Pharma's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Teva Pharma stock will not fluctuate a lot when Teva Pharma's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Teva Pharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Teva Pharma's short interest history, or implied volatility extrapolated from Teva Pharma options trading.
Currently Active Assets on Macroaxis
When determining whether Teva Pharma Industries offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Teva Pharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Teva Pharma Industries Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Teva Pharma Industries Stock:Check out the analysis of Teva Pharma Correlation against competitors. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Complementary Tools for Teva Stock analysis
When running Teva Pharma's price analysis, check to measure Teva Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharma is operating at the current time. Most of Teva Pharma's value examination focuses on studying past and present price action to predict the probability of Teva Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharma's price. Additionally, you may evaluate how the addition of Teva Pharma to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |
Is Teva Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Teva Pharma. If investors know Teva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Teva Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.4 | Earnings Share (0.50) | Revenue Per Share 14.161 | Quarterly Revenue Growth 0.148 | Return On Assets 0.0454 |
The market value of Teva Pharma Industries is measured differently than its book value, which is the value of Teva that is recorded on the company's balance sheet. Investors also form their own opinion of Teva Pharma's value that differs from its market value or its book value, called intrinsic value, which is Teva Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Teva Pharma's market value can be influenced by many factors that don't directly affect Teva Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Teva Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Teva Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Teva Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.